- Patent Title: Serpina1 siRNAs: compositions of matter and methods of treatment
-
Application No.: US16513903Application Date: 2019-07-17
-
Publication No.: US10935917B2Publication Date: 2021-03-02
- Inventor: Alfica Sehgal , David Bumcrot , Brian Bettencourt
- Applicant: ALNYLAM PHARMACEUTICALS, INC.
- Applicant Address: US MA Cambridge
- Assignee: ALNYLAM PHARMACEUTICALS, INC.
- Current Assignee: ALNYLAM PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Nixon Peabody LLP
- Agent Mark J. FitzGerald; Nicole D. Kling
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N15/11 ; G03G15/00 ; C12N15/113 ; G03G15/08
Abstract:
The technology described herein relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the Serpina 1 gene, and methods of using such dsRNA compositions to inhibit expression of Serpina 1.
Public/Granted literature
- US20190354055A1 SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT Public/Granted day:2019-11-21
Information query
